BUZZ-CVS 因上调 2025 年利润预期而上涨

路透中文
01 May
BUZZ-CVS 因上调 2025 年利润预期而上涨

5月1日 - ** 医疗保健集团CVS Health CVS.N股价盘前上涨7.2%至71.50美元

** 公司上调 (link) 全年利润预期,因各项业务表现强劲

** 每股盈利预期从之前的5.75-6美元上调至6-6.20美元。

** 第一季度每股收益为2.25美元,高于分析师预期的1.70美元,数据来源于LSEG。

** 该公司称,其药房福利管理部门计划将礼来LLY.N的减肥药Zepbound从其符合报销条件的药品名单中剔除,保留诺和诺德NOVOb.CO的 (link) Wegovy。

** 截至上次收盘,股价累计上涨 48.6

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10